Study Type
Interventional - Drug
Randomized, placebo controlled, double-blind, parallel group, dose-finding Phase 2 study to evaluate efficacy and safety of BAY 2433334 in patients following an acute non-cardioembolic ischemic stroke.
Interventional - Drug
Randomized placebo controlled double-blind parallel group trial
25
250
2020 - 2021
Bayer
Back To Top